檢索結果 - Paul T. Kirschmeier

Refine Results
  1. 1
    Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors

    Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors 由 Andrea Basso, Paul T. Kirschmeier, W. Robert Bishop

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines

    AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines 由 Sandra Koseoglu, Zhuomei Lu, C. Chandra Kumar, Paul T. Kirschmeier, Jun Zou

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling

    The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling 由 Andrea Basso, Asra Mirza, Gongjie Liu, Brian J. Long, W. Robert Bishop, Paul T. Kirschmeier

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family.

    Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family. 由 Gerard M. Housey, C A O'Brian, Mark D. Johnson, Paul T. Kirschmeier, I. Bernard Weinstein

    出版 1987
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules

    Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the Microtubules 由 Hena R. Ashar, Linda James, Kimberly Gray, Donna Carr, Stuart Black, Lydia Armstrong, W. Robert Bishop, Paul T. Kirschmeier

    出版 2000
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies

    A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies 由 John Nemunaitis, Karen Small, Paul T. Kirschmeier, Da Zhang, Yali Zhu, Ying‐Ming Jou, Paul Statkevich, Siu‐Long Yao, Rajat Bannerji

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors

    Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors 由 Terrill K. McClanahan, Sandra Koseoglu, Kathleen B. Smith, Jeffrey Grein, Eric A. Gustafson, Stuart Black, Paul T. Kirschmeier, Ahmed A. Samatar

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors

    K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors 由 David B. Whyte, Paul T. Kirschmeier, Tish Hockenberry, Irma Nunez-Oliva, Linda James, Joseph J. Catino, W. Robert Bishop, Jin-Keon Pai

    出版 1997
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches

    Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches 由 Luquan Wang, Qun Wu, Ping Qiu, Asra Mirza, Marnie McGuirk, Paul T. Kirschmeier, Jonathan Greene, Yaolin Wang, Cecil B. Pickett, Suxing Liu

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

    Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia 由 David G. Peters, Russell R. Hoover, Melissa J. Gerlach, Eugene Y. Koh, Haiyan Zhang, Kevin S. Choe, Paul T. Kirschmeier, W. Robert Bishop, George Q. Daley

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I

    Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I 由 Fang L. Zhang, Paul T. Kirschmeier, Donna Carr, Linda James, Richard Bond, Lynn Wang, Robert Patton, William T. Windsor, Rosalinda Syto, Rumin Zhang, W. Robert Bishop

    出版 1997
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification

    Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification 由 Patrick J. Roberts, Natalia Mitin, Patricia J. Keller, Emily J. Chenette, James P. Madigan, Rachel O. Currin, Adrienne D. Cox, Oswald Wilson, Paul T. Kirschmeier, Channing J. Der

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Transcriptional Regulation during p21/-induced Apoptosis in Human Ovarian Cancer Cells

    Transcriptional Regulation during p21/-induced Apoptosis in Human Ovarian Cancer Cells 由 Qun Wu, Paul T. Kirschmeier, Tish Hockenberry, Tong‐Yuan Yang, Diana Brassard, Luquan Wang, Terri McClanahan, Stuart Black, Giovanni Rizzi, Mary Lynn Musco, Asra Mirza, Suxing Liu

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Noninvasive Detection of Response and Resistance in <i>EGFR</i>-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA

    Noninvasive Detection of Response and Resistance in <i>EGFR</i>-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA 由 Geoffrey R. Oxnard, Cloud P. Paweletz, Yanan Kuang, Stacy L. Mach, Allison O’Connell, Melissa M. Messineo, Jason J. Luke, Mohit Butaney, Paul T. Kirschmeier, David M. Jackman, Pasi A. Jänne

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

    Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway 由 Asra Mirza, Marnie McGuirk, Tish Hockenberry, Qun Wu, Hena R. Ashar, Stuart Black, Shu Fen Wen, Luquan Wang, Paul T. Kirschmeier, W. Robert Bishop, Loretta L. Nielsen, Cecil B. Pickett, Suxing Liu

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Novel Tricyclic Inhibitors of Farnesyl Protein Transferase

    Novel Tricyclic Inhibitors of Farnesyl Protein Transferase 由 W. Robert Bishop, Richard Bond, Joanne Petrin, Lynn Wang, Robert Patton, Ronald J. Doll, George Njoroge, Joseph J. Catino, Jerome Schwartz, William T. Windsor, Rosalinda Syto, Jeffrey H. Schwartz, Donna Carr, Linda James, Paul T. Kirschmeier

    出版 1995
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

    Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients 由 Cloud P. Paweletz, Adrian G. Sacher, Chris K. Raymond, Ryan S. Alden, Allison O’Connell, Stacy L. Mach, Yanan Kuang, Leena Gandhi, Paul T. Kirschmeier, Jessie M. English, Lee P. Lim, Pasi A. Jänne, Geoffrey R. Oxnard

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity

    Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity 由 Juan J. Miret, Paul T. Kirschmeier, Shohei Koyama, Mingrui Zhu, Yvonne Y. Li, Yujiro Naito, Min Wu, Venkat S. Malladi, Wei Huang, William H. Walker, Sangeetha Palakurthi, Glenn Dranoff, Peter S. Hammerman, Chad V. Pecot, Kwok‐Kin Wong, Esra A. Akbay

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

    Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer 由 Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima, David A. Barbie

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor

    Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor 由 David Parry, Timothy J. Guzi, Fergus Shanahan, Nicole R. Davis, Deepa Prabhavalkar, Derek Wiswell, Wolfgang Seghezzi, Kamil Paruch, Michael P. Dwyer, Ronald J. Doll, Amin A. Nomeir, William T. Windsor, Thierry Fischmann, Yaolin Wang, Martin Oft, Taiying Chen, Paul T. Kirschmeier, Emma Lees

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: